A novel quantification platform for point-of-care testing of circulating MicroRNAs based on allosteric spherical nanoprobe

MiRNA-150, a gene regulator that has been revealed to be abnormal expression in non-small cell lung cancer (NSCLC), can be regarded as a serum indicator for diagnosis and monitoring of NSCLC. Herein, a new sort of nanoprobe, termed allosteric spherical nanoprobe, was first developed to sense miRNA-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Huiyan, Yuan, Changjing, Liu, Yu, Li, Zhi, Xia, Ke, Li, Mengya, Xie, Fengxin, Chen, Qinghai, Chen, Ming, Fu, Weiling, Zhang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603675/
https://www.ncbi.nlm.nih.gov/pubmed/33129342
http://dx.doi.org/10.1186/s12951-020-00717-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603675/
https://www.ncbi.nlm.nih.gov/pubmed/33129342
http://dx.doi.org/10.1186/s12951-020-00717-z

Ejemplares similares